PARP1 and ovarian carcinoma: Lastly, naturally formed exosomes could be used as a delivery method for CRISPR/Cas9 systems, as Kim et al., 2017 showed that such methods were able to induce apoptosis in ovarian cancer cells through the suppressed expression of poly (ADP-ribose) polymerase-1 (PARP-1).